参考文献/References:
[1] Liu D,Huang SY,Sun JH,et al. Sepsis-induced immunosuppression:mechanisms,diagnosis and current treatment options[J]. Mil Med Res,2022,9(1):56.
[2] Mushtaq A,Kazi F. Updates in sepsis management [J]. Lancet Infect Dis,2022,22(1):24.
[3] Cecconi M,Evans L,Levy M,et al. Sepsis and septic shock[J]. Lancet,2018,392(10141):75-87.
[4] Ehrman RR,Sullivan AN,Favot MJ,et al. Pathophysiology,echocardiographic evaluation,biomarker findings,and prognostic implications of septic cardiomyopathy:a review of the literature[J]. Crit Care,2018,22(1):112.
[5] Giustozzi M,Ehrlinder H,Bongiovanni D,et al. Coagulopathy and sepsis:pathophysiology,clinical manifestations and treatment[J]. Blood Rev,2021,50:100864.
[6] JJi T,Liu Q,Yu L,et al. GAS6 attenuates sepsis-induced cardiac dysfunction through NLRP3 inflammasome-dependent mechanism[J]. Free Radic Biol Med,2024,210:195-211.
[7] Lv X,Wang H. Pathophysiology of sepsis-induced myocardial dysfunction[J]. Mil Med Res,2016,3:30.
[8] Tan Y,Wan HH,Sun MM,et al. Cardamonin protects against lipopolysaccharide-induced myocardial contractile dysfunction in mice through Nrf2-regulated mechanism[J]. Acta Pharmacol Sin,2021,42(3):404-413.
[9] Lu SM,Yang B,Tan ZB,et al. TaoHe ChengQi decoction ameliorates sepsis-induced cardiac dysfunction through anti-ferroptosis via the Nrf2 pathway[J]. Phytomedicine,2024,129:155597.
[10] Fang Z,Wang G,Huang R,et al. Astilbin protects from sepsis-induced cardiac injury through the NRF2/HO-1 and TLR4/NF-κB pathway[J]. Phytother Res,2024,38(2):1044-1058.
[11] He H,Jiang H,Chen Y,et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity[J]. Nat Commun,2018,9(1):2550.
[12] Wang M,Xu B,Liu L,et al. Oridonin attenuates dextran sulfate sodium?induced ulcerative colitis in mice via the Sirt1/NF?κB/p53 pathway[J]. Mol Med Rep,2022,26(4):312.
[13] Wang S,Yang H,Yu L,et al. Oridonin attenuates Aβ1-42-induced neuroinflammation and inhibits NF-κB pathway[J]. PLoS One,2014,9(8):e104745.
[14] Zhang ZY,Daniels R,Schluesener HJ. Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis[J]. J Cell Mol Med,2013,17(12):1566-1576.
[15] Jia T,Cai M,Ma X,et al. Oridonin inhibits IL-1β-induced inflammation in human osteoarthritis chondrocytes by activating PPAR-γ[J]. Int Immunopharmacol,2019,69:382-388.
[16] Gao RF,Li X,Xiang HY,et al. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice[J]. Int Immunopharmacol,2021,90:107133.
[17] Carbone F,Liberale L,Preda A,et al. Septic cardiomyopathy:from pathophysiology to the clinical setting[J]. Cells,2022,11(18):2833.
[18] Zhang K,Wang Y,Chen S,et al. TREM2hi resident macrophages protect the septic heart by maintaining cardiomyocyte homeostasis [J]. Nat Metab,2023,5(1):129-146.
[19] Zhang Q,Liu J,Duan H,et al. Activation of Nrf2/HO-1 signaling:an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress[J]. J Adv Res,2021,34:43-63.
[20] Zhang Q,Wang L,Wang S,et al. Signaling pathways and targeted therapy for myocardial infarction[J]. Signal Transduct Target Ther,2022,7(1):78.
[21] Zhang Q,Luo C,Li Z,et al. Astaxanthin activates the Nrf2/Keap1/HO-1 pathway to inhibit oxidative stress and ferroptosis,reducing triphenyl phosphate (TPhP)-induced neurodevelopmental toxicity[J]. Ecotoxicol Environ Saf,2024,271:115960.
[22] Sun YY,Zhu HJ,Zhao RY,et al. Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2/HO-1 pathway in MCAO mice[J]. Redox Biol,2023,66:102852.
[23] Li L,Luo W,Qian Y,et al. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses[J]. Phytomedicine,2019,59:152774.
[24] Li J,Deng SH,Li J,et al. Obacunone alleviates ferroptosis during lipopolysaccharide-induced acute lung injury by upregulating Nrf2-dependent antioxidant responses[J]. Cell Mol Biol Lett,2022,27(1):29.
[25] Yao H,He Q,Huang C,et al. Panaxatriol saponin ameliorates myocardial infarction-induced cardiac fibrosis by targeting Keap1/Nrf2 to regulate oxidative stress and inhibit cardiac-fibroblast activation and proliferation[J]. Free Radic Biol Med,2022,190:264-275.
[26] Du X,Que W,Hu X,et al. Oridonin prolongs the survival of mouse cardiac allografts by attenuating the NF-κB/NLRP3 pathway[J]. Front Immunol,2021,12:719574.
[27] Yang H,Lv H,Li H,et al. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways[J]. Cell Commun Signal,2019,17(1):62.
[28] Li N,Zhou H,Wu H,et al. STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction,inflammation,apoptosis and pyroptosis by activating NLRP3[J]. Redox Biol,2019,24:101215.
相似文献/References:
[1]王猛 江洪.肠道菌群及其代谢产物与心房颤动的研究进展[J].心血管病学进展,2022,(3):214.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
WANG Meng,JIANG Hong.Gut Microbiota an d Its Metabolites in Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(5):214.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[2]李彬 刘江文 王凤媛 文英 蒋学俊.4-辛基衣康酸减轻脂多糖诱导的心肌损伤[J].心血管病学进展,2023,(1):82.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.018]
LI Bin,LIU Jiangwen,WANG Fengyuan,et al.4-Octyl Itaconate Attenuates Lipopolysaccharide-Induced Myocardial Injury[J].Advances in Cardiovascular Diseases,2023,(5):82.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.018]
[3]蒋振江 刘富强 王军奎.肠道菌群与肥胖的关系研究进展[J].心血管病学进展,2023,(3):265.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.017]
JIANG Zhenjiang,LIU Fuqiang,WANG Junkui.The Relationship Between Gut Microbiota and Obesity[J].Advances in Cardiovascular Diseases,2023,(5):265.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.017]
[4]董文晟 高义鹏 叶云佳 李康 张鑫.鸢尾素对脂多糖诱导的内皮细胞损伤影响[J].心血管病学进展,2025,(1):71.[doi:10.16806/j.cnki.issn.1004-3934.2025.01.016]
DONG Wensheng,GAO Yipeng,YE Yunjia,et al.Effects of Irisin on Lipopolysaccharide-Induced Endothelial Injury[J].Advances in Cardiovascular Diseases,2025,(5):71.[doi:10.16806/j.cnki.issn.1004-3934.2025.01.016]